[Reflections on the royal decree project for the dispensing of drugs in special circumstances].
Girona Brumós
Lourdes
L
Juárez Giménez
Juan Carlos
JC
D018943:Anthracyclines / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D009202:Cardiomyopathies / Q000139:chemically induced / Q000188:drug therapy; D057176:Compassionate Use Trials / Q000191:economics / Q000331:legislation & jurisprudence*; D016527:Drug Costs; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy; D000069579:Ranibizumab; D011929:Razoxane / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D013030:Spain
D018943:Anthracyclines; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D011929:Razoxane; D000069579:Ranibizumab